Soo Khim Chan

1.1k citations
29 papers · 821 indexed · 1 hit paper · h-index 11

Soo Khim Chan

29 papers receiving 806 citations

Hit Papers

COVID-19 vaccine development and a potential nanomaterial...4922020202620222024100200300400

Peers

Soo Khim Chan
Comparison fields: 5 of 108
  • Infectious Diseases 322
  • Biotechnology 65
  • Immunology 130
  • Modeling and Simulation 26
  • Pharmaceutical Science 34
Replace Matthew D. Shin with:
Matthew D. Shin United States
Young Hun Chung United States
Chenjian Gu China
Cuiling Zhang China
Asghar Abdoli Iran
Deena A. Oren United States
Abigail E. Powell United States
Kapil Maithal India
Hangyu Zhou China
Veronique Beiss United States
Soo Khim Chan relative to Matthew D. Shin United States Matthew D. Shin's profile →
Citations per field
00.5×
Matthew D. Shin · 1×
Citations per year

Countries citing papers authored by Soo Khim Chan

Since Specialization
Citations

This map shows the geographic impact of Soo Khim Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soo Khim Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soo Khim Chan more than expected).

Fields of papers citing papers by Soo Khim Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soo Khim Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soo Khim Chan. The network helps show where Soo Khim Chan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Soo Khim Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Soo Khim Chan Line = papers co-authored together Soo Khim Chan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202312
2 20237
3 20225
4 20222
5 20213
6 20216
7 202110
8 202110
9
COVID-19 vaccine development and a potential nanomaterial path forwardbreakdown →
2020492
10 20192
11 20192
12 201926
13 20192
14 20183
15 201722
16 20174
17 201710
18 20169
19 201615
20 200121

About Soo Khim Chan

Soo Khim Chan is a scholar working on Biotechnology, Ecology and Infectious Diseases, having authored 29 papers that have together received 821 indexed citations. Recurring topics across this work include Bacteriophages and microbial interactions (10 papers), Transgenic Plants and Applications (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Plant Virus Research Studies (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), RNA Interference and Gene Delivery (4 papers), Biosensors and Analytical Detection (4 papers) and SARS-CoV-2 detection and testing (3 papers). The work is most often cited by research in Infectious Diseases (322 citations), Biotechnology (65 citations) and Immunology (130 citations). Soo Khim Chan has collaborated with scholars based in United States, Malaysia and Japan. Frequent co-authors include Nicole F. Steinmetz, Sourabh Shukla, Veronique Beiss, Jonathan K. Pokorski, Oscar A. Ortega‐Rivera, Young Hun Chung, M. Sack, Matthew D. Shin, Theam Soon Lim and David M. Wirth.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026